Bariatric care is entering a new era. As endoscopic weight-loss procedures become safer, less invasive, and more durable, experts say demand for bariatric interventions is set to rise—even as GLP-1 medications surge.
In a recent episode of The Scope, gastroenterologists David Robbins, MD, and Steven Shamah, MD, discuss advances in endoscopic bariatrics, the relatively modest training needed to offer these procedures, reimbursement realities, and why physicians will play an even bigger role as obesity continues to grow.